Small cell lung cancer (SCLC) is a highly invasive lung tumor, especially in heavy smokers. Due to its rapid spread, most patients can only be treated with chemotherapy, and its initial anti-tumor effect is very significant. However, as treatment progresses, patients often experience recurrence.
March 21, 2024
Women's Day | FDC pays tribute to every shining "she"!
March 8, 2024
FDC Wish you a Good Start at the Year of the Dragon
February 18, 2024
FDC wish you a happy new year
January 25, 2024
FDC was established in 2010, focusing on the field of small molecule chemical new drugs. For 13 years, as a high-end reagent brand, FDC's business has covered the research and development, production, and sales of high-end chemical reagents, with customers in multiple countries around the world. It has established deep cooperative relationships with well-known pharmaceutical companies and research institutes in Asia, Europe, America, and other regions.
December 28, 2023
During August 3-4, 2023, the 5th CMC-China China International Bio&Chemical Pharmaceutical Expo was grandly held at the Suzhou International Expo Center. This exhibition was initiated by Xiangrong Technology and held in collaboration with multiple units. The exhibition gathers hundreds of industry exhibitors, showcasing products and services covering the entire lifecycle and upstream and downstream industry chains of large and small molecules, generic and innovative drugs, active pharmaceutical ingredients and drug formulations, traditional Chinese medicine and western medicine. FDC made its debut at this exhibition.
August 6, 2023
FDC has successfully passed the re examination of the ISO9001:2015 quality management system by the Great Wall (Tianjin) Quality Assurance Center
March 29, 2022
